RE:RE:New Deal for Adstiladrin enriquesuave wrote: Basically paying upfront $500 Million for 5.1% and up to 8 % of sales of Adstiladrin over next 10 years or so. That means they expect sales of up to $1 Billion per year. Crazy, our turn will hopefully come soon.
enriquesuave, very good catch.
Let's see the difference between Adstiladrin & Ruvidar(TLD-1433).
CR%...
Adstiladrin 24%CR at 12 months.
Ruvidar 36%CR(and increasing) at 12 months.
Cost...
Adstiladrin for one year treatment cost $268kUS($364kCan).
Ruvidar cost $200k.US($300k.Can) for a one and done treatment.
For BCG-Resistant patients(and doctors) the choice will be easy.
enriquesuave you said " TLT should get double" I say double is a minimum.
In conclusion;
$500 millionUS for a treatment(Adstiladrin) that has a lower efficacy and cost more than Ruvidar.
I salivate at the idea of a big pharma deal for Ruvidar.